554 related articles for article (PubMed ID: 20566584)
21. Multiple endocrine neoplasia type 1: a chromatin writer's block.
Dreijerink KM; Lips CJ; Timmers HT
J Intern Med; 2009 Jul; 266(1):53-9. PubMed ID: 19522825
[TBL] [Abstract][Full Text] [Related]
22. Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-beta pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice.
Hussein N; Lu J; Casse H; Fontanière S; Morera AM; Guittot SM; Calender A; Di Clemente N; Zhang CX
Endocr Relat Cancer; 2008 Mar; 15(1):217-27. PubMed ID: 18310289
[TBL] [Abstract][Full Text] [Related]
23. Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1.
Owens M; Ellard S; Vaidya B
Clin Endocrinol (Oxf); 2008 Mar; 68(3):350-4. PubMed ID: 17854391
[TBL] [Abstract][Full Text] [Related]
24. Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas.
Haven CJ; van Puijenbroek M; Tan MH; Teh BT; Fleuren GJ; van Wezel T; Morreau H
Clin Endocrinol (Oxf); 2007 Sep; 67(3):370-6. PubMed ID: 17555500
[TBL] [Abstract][Full Text] [Related]
25. Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas.
Goebel SU; Heppner C; Burns AL; Marx SJ; Spiegel AM; Zhuang Z; Lubensky IA; Gibril F; Jensen RT; Serrano J
J Clin Endocrinol Metab; 2000 Jan; 85(1):116-23. PubMed ID: 10634374
[TBL] [Abstract][Full Text] [Related]
26. Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance?
Bartsch DK; Langer P; Wild A; Schilling T; Celik I; Rothmund M; Nies C
Surgery; 2000 Dec; 128(6):958-66. PubMed ID: 11114630
[TBL] [Abstract][Full Text] [Related]
27. MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1.
Balogh K; Hunyady L; Patocs A; Gergics P; Valkusz Z; Toth M; Racz K
Clin Endocrinol (Oxf); 2007 Nov; 67(5):727-34. PubMed ID: 17953629
[TBL] [Abstract][Full Text] [Related]
28. Somatic mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in patients with sporadic, nonfamilial primary hyperparathyroidism.
Sato K; Yamazaki K; Zhu H; Kanbe M; Iihara M; Wada Y; Tanaka R; Okamoto T; Ito Y; Obara T
Surgery; 2000 Mar; 127(3):337-41. PubMed ID: 10715991
[TBL] [Abstract][Full Text] [Related]
29. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
[TBL] [Abstract][Full Text] [Related]
30. [The role and mechanism of high expression of cyclin B2 in MEN1 insulinoma].
Wu T; Huang XH
Sheng Li Xue Bao; 2011 Dec; 63(6):555-64. PubMed ID: 22193451
[TBL] [Abstract][Full Text] [Related]
31. Tumour suppressor menin is essential for development of the pancreatic endocrine cells.
Fontanière S; Duvillié B; Scharfmann R; Carreira C; Wang ZQ; Zhang CX
J Endocrinol; 2008 Nov; 199(2):287-98. PubMed ID: 18772165
[TBL] [Abstract][Full Text] [Related]
32. Reconstituted expression of menin in Men1-deficient mouse Leydig tumour cells induces cell cycle arrest and apoptosis.
Hussein N; Casse H; Fontanière S; Morera AM; Asensio MJ; Bakeli S; Lu JL; Coste I; Di Clemente N; Bertolino P; Zhang CX
Eur J Cancer; 2007 Jan; 43(2):402-14. PubMed ID: 17184987
[TBL] [Abstract][Full Text] [Related]
33. Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases.
Valdes N; Alvarez V; Diaz-Cadorniga F; Aller J; Villazon F; Garcia I; Herrero A; Coto E
Anticancer Res; 1998; 18(4A):2685-9. PubMed ID: 9703929
[TBL] [Abstract][Full Text] [Related]
34. Tumor suppressor menin: the essential role of nuclear localization signal domains in coordinating gene expression.
La P; Desmond A; Hou Z; Silva AC; Schnepp RW; Hua X
Oncogene; 2006 Jun; 25(25):3537-46. PubMed ID: 16449969
[TBL] [Abstract][Full Text] [Related]
35. Accelerated proliferation and differential global gene expression in pancreatic islets of five-week-old heterozygous Men1 mice: Men1 is a haploinsufficient suppressor.
Lejonklou MH; Barbu A; Stålberg P; Skogseid B
Endocrinology; 2012 Jun; 153(6):2588-98. PubMed ID: 22492302
[TBL] [Abstract][Full Text] [Related]
36. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis.
Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX
Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767
[TBL] [Abstract][Full Text] [Related]
37. Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas.
Hessman O; Lindberg D; Skogseid B; Carling T; Hellman P; Rastad J; Akerström G; Westin G
Cancer Res; 1998 Feb; 58(3):377-9. PubMed ID: 9458074
[TBL] [Abstract][Full Text] [Related]
38. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
[TBL] [Abstract][Full Text] [Related]
39. Multiple endocrine neoplasia type 1.
Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of the Danish families with multiple endocrine neoplasia type 1.
Jäger AC; Friis-Hansen L; Hansen TV; Eskildsen PC; Sølling K; Knigge U; Hansen CP; Andersen PH; Brixen K; Feldt-Rasmussen U; Kroustrup JP; Mollerup CL; Rehfeld JF; Blichert-Toft M; Nielsen FC
Mol Cell Endocrinol; 2006 Apr; 249(1-2):123-32. PubMed ID: 16563611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]